Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04461821 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents

Study acronym: EBECA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. 4 versions Re-verified since Dec 10, 2021, no change to tracked fieldsv5-v8
  2. Site contact updatedv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 2020 to Sep 11, 2020
    • Site details revised
    v3
  4. Start date: Jul 2020 to Sep 2020v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is to investigate breath analysis (breath metabolomics) combined with established bioinformatic tools as a platform for companion diagnostics.
Trial Details
NCT Number NCT04461821
Lead Sponsor University Children's Hospital Basel
Collaborators: Swiss National Science Foundation, Fondation Botnar (Switzerland)
Conditions
(from sponsor)		 Respiratory Diseases, Neurological Disorders, Type 1 Diabetes
Related terms Diabetes Mellitus, Type 1, Nervous System Diseases, Respiratory Tract Diseases
Enrollment 3,600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov